Osteotec and Additive Surgical Collaborate to Introduce 3D-Printed Spine Technology in the UK

Friday, June 14, 2024

Osteotec, a leading manufacturer and distributor of medical devices, has announced a new partnership with Additive Surgical, an innovative company based in Adelaide known for its pioneering 3D-printed spinal implant technologies.

This collaboration marks a significant milestone for Osteotec as it expands into the spine sector, promising to provide advanced solutions and unprecedented support to orthopaedic and neurosurgeons across the UK.

Founded in 2020, Additive Surgical is the first Australian company to offer off-the-shelf 3D-printed titanium spinal implants. Their portfolio includes the proprietary PorOssity™ technology, featuring intricate biomimetic lattices and targeted porosity that promote bone growth, capabilities previously unattainable through traditional manufacturing methods.

"This partnership underscores our commitment to bringing state-of-the-art technologies to the UK market," said Lisa Watts, National Spine Sales Manager at Osteotec.

"By collaborating with Additive Surgical, we aim to offer surgeons innovative, customizable products that enhance patient outcomes. We are eager to integrate Additive Surgical's unique 3D-printed implants into our product lineup, providing UK surgeons with unmatched solutions for their patients."

Additive Surgical empowers surgeons with substantial design input, enabling rapid iteration and customization of implant designs.

Their clinician-led innovation model has earned partnerships with leading orthopaedic and neurosurgeons in Australia and New Zealand, establishing Additive Surgical at the forefront of the medtech industry.

"Our collaboration with Osteotec represents a significant advancement in our mission to introduce cutting-edge spinal implant technology globally."

"Osteotec's esteemed reputation and extensive network within the UK medical community make them an ideal partner to introduce our innovative 3D-printed solutions to UK surgeons. We look forward to launching officially in the UK market in spring 2025."

Both companies are excited to engage with leading UK surgeons in the coming months to address specific clinical challenges and develop tailored solutions.

This partnership not only highlights Osteotec's ongoing growth and innovation but also reaffirms its leadership in the orthopaedic and spine medical device industry.






Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital Congress